Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure RegistryPloS one, 2024-05, Vol.19 (5), p.e0303348-e0303348 [Peer Reviewed Journal]Copyright: © 2024 Lindberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0303348 ;PMID: 38787867Full text available |
2 |
Material Type: Article
|
![]() |
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESCEuropean journal of heart failure, 2024-05 [Peer Reviewed Journal]Attribution - NonCommercial ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.3295Digital Resources/Online E-Resources |
3 |
Material Type: Article
|
![]() |
The management of heart failure in Sweden-the physician's perspective: a surveyFrontiers in cardiovascular medicine, 2024-05, Vol.11, p.1385281-1385281 [Peer Reviewed Journal]2024 Ferrannini, Biber, Abdi, Ståhlberg, Lund and Savarese. ;2024 Ferrannini, Biber, Abdi, Ståhlberg, Lund and Savarese. 2024 Ferrannini, Biber, Abdi, Ståhlberg, Lund and Savarese ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2024.1385281 ;PMID: 38807949Full text available |
4 |
Material Type: Article
|
![]() |
More Evidence That HF With Normal EF Is Distinct From HF Below Normal EFJournal of the American College of Cardiology, 2024-05, Vol.83 (18), p.1740-1742 [Peer Reviewed Journal]2024 American College of Cardiology Foundation ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2024.03.373 ;PMID: 38537914Full text available |
5 |
Material Type: Article
|
![]() |
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure RegistryEuropean journal of heart failure, 2024-05 [Peer Reviewed Journal]ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.3272Digital Resources/Online E-Resources |
6 |
Material Type: Article
|
![]() |
Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction – a secondary analysis of TOPCATThe American heart journal, 2024-05, Vol.271, p.136-147 [Peer Reviewed Journal]2024 The Author(s) ;Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. ;2024. The Author(s) ;ISSN: 0002-8703 ;ISSN: 1097-6744 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2024.02.021 ;PMID: 38412897Digital Resources/Online E-Resources |
7 |
Material Type: Article
|
![]() |
Generalizable Approach to Quantifying Guideline-Directed Medical TherapyCirculation. Heart failure, 2024-05, Vol.17 (5), p.e011164 [Peer Reviewed Journal]EISSN: 1941-3297 ;DOI: 10.1161/CIRCHEARTFAILURE.123.011164 ;PMID: 38742418Digital Resources/Online E-Resources |
8 |
Material Type: Article
|
![]() |
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes RegistriesEuropean heart journal. Cardiovascular pharmacotherapy, 2024-04 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 2055-6845 ;EISSN: 2055-6845 ;DOI: 10.1093/ehjcvp/pvae026 ;PMID: 38632048Digital Resources/Online E-Resources |
9 |
Material Type: Article
|
![]() |
Inflammation and myeloperoxidase - The next treatment targets in heart failure?International journal of cardiology, 2024-04, Vol.401, p.131834 [Peer Reviewed Journal]EISSN: 1874-1754 ;DOI: 10.1016/j.ijcard.2024.131834 ;PMID: 38325440Digital Resources/Online E-Resources |
10 |
Material Type: Article
|
![]() |
Cause-specific death in heart failure across the ejection fraction spectrum: A comprehensive assessment of over 100 000 patients in the Swedish Heart Failure RegistryEuropean journal of heart failure, 2024-04 [Peer Reviewed Journal]ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.3230Digital Resources/Online E-Resources |
11 |
Material Type: Article
|
![]() |
Preemptive Versus Urgent Heart Failure Hospitalization as a Surrogate for Mortality Risk in Heart FailureCirculation (New York, N.Y.), 2024-04, Vol.149 (14), p.1062-1064 [Peer Reviewed Journal]ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.123.068066 ;PMID: 38557123Digital Resources/Online E-Resources |
12 |
Material Type: Article
|
![]() |
An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney DiseaseReviews in cardiovascular medicine, 2024-04, Vol.25 (4), p.144 [Peer Reviewed Journal]ISSN: 1530-6550 ;EISSN: 2153-8174 ;DOI: 10.31083/j.rcm2504144Full text available |
13 |
Material Type: Article
|
![]() |
Does Heterogeneity Exist in Treatment Associations With Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?Journal of cardiac failure, 2024-04, Vol.30 (4), p.541 [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. ;ISSN: 1532-8414 ;EISSN: 1532-8414 ;DOI: 10.1016/j.cardfail.2023.08.008 ;PMID: 37634573Digital Resources/Online E-Resources |
14 |
Material Type: Article
|
![]() |
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure RegistryEuropean journal of heart failure, 2024-04, Vol.26 (4), p.854 [Peer Reviewed Journal]2024 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.3112 ;PMID: 38131248Digital Resources/Online E-Resources |
15 |
Material Type: Article
|
![]() |
N‐terminal pro‐B‐type natriuretic peptide concentrations, testing and associations with worsening heart failure eventsESC Heart Failure, 2024-04, Vol.11 (2), p.759-771 [Peer Reviewed Journal]2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.14613 ;PMID: 38115625Full text available |
16 |
Material Type: Article
|
![]() |
Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysisESC Heart Failure, 2024-03 [Peer Reviewed Journal](c) 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.14626 ;PMID: 38549197Full text available |
17 |
Material Type: Article
|
![]() |
Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent mannerDigital Resources/Online E-Resources |
18 |
Material Type: Article
|
![]() |
Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent mannerNature communications, 2024-03, Vol.15 (1), p.2358-2358 [Peer Reviewed Journal]2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-46384-8 ;PMID: 38509128Full text available |
19 |
Material Type: Article
|
![]() |
Rationale and protocol of the LAQUA-HF trial: a factorial randomised controlled trial evaluating the effects of neurohormonal and diuretic agents on health-status reported outcomes in heart failure patientsBMJ open, 2024-02, Vol.14 (2), p.e076519-e076519 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-076519 ;PMID: 38355194Full text available |
20 |
Material Type: Article
|
![]() |
Novel Trial Designs in Heart Failure: Using Digital Health Tools to Increase PragmatismCurrent heart failure reports, 2024-02, Vol.21 (1), p.5 [Peer Reviewed Journal]2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;EISSN: 1546-9549 ;DOI: 10.1007/s11897-023-00640-y ;PMID: 38153611Digital Resources/Online E-Resources |